Who
Sumit Aggarwal
President and CEO
Company insider
Files Form 4 as: President and CEO, Eloxx Pharmaceuticals.
In numbers
- Trades disclosed
- 54
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2021
- Last trade
- 10 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 10 Jun 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —328,833 at $0.00 | filing |
| 10 Jun 2026filed 10 Jun 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —328,833 at $0.00 | filing |
| 28 Feb 2026filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —260,946 at $0.00 | filing |
| 28 Feb 2026filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —260,946 at $0.00 | filing |
| 28 Feb 2026filed 8 May 2026 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $39K260,946 at $0.15 | filing |
| 28 Feb 2026filed 8 May 2026 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $39K260,946 at $0.15 | filing |
| 24 Jan 2026filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 24 Jan 2026filed 8 May 2026 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —15,000 | filing |
| 24 Jan 2026filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 24 Jan 2026filed 8 May 2026 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —15,000 | filing |
| 19 Sep 2025filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,597,090 at $0.00 | filing |
| 19 Sep 2025filed 8 May 2026 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 19 Sep 2025filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,597,090 at $0.00 | filing |
| 19 Sep 2025filed 8 May 2026 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 14 Aug 2025filed 8 May 2026 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $20196,880 at $0.0001 | filing |
| 14 Aug 2025filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —60,390 at $0.00 | filing |
| 14 Aug 2025filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —68,700 at $0.00 | filing |
| 14 Aug 2025filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 14 Aug 2025filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —42,790 at $0.00 | filing |
| 14 Aug 2025filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —60,390 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.